title: Prospective age-matching in elderly kidney transplant recipients--a 5-year analysis of the Eurotransplant Senior Program.
abstract: Renal transplantation faces challenges: the organ shortage resulting in extended waiting times and an aging population resulting in death with a functioning graft. The Eurotransplant Senior Program (ESP) allocates kidneys within a narrow geographic area from donors aged >/=65 years to recipients >/=65 years regardless of HLA. This analysis investigates the impact of the ESP on waiting time, graft and patient survival. The ESP group (n = 1406, old to old) was compared to two groups allocated via the Eurotransplant Kidney Allocation System (ETKAS) with either similar donor age (old to any [O/A], donor age >/=65, n = 446) or recipient age (any to old, [A/O], recipient age 60-64, n = 1687). All patients were transplanted between 1999 and 2004. Since initiation of the ESP (1999), availability of elderly donors doubled and waiting time for ESP patients decreased. Local allocation led to shorter cold ischemia time (11.9 vs. >17.0 h, p < 0.001) and less delayed graft function (DGF, ESP 29.7% vs. O/A 36.2%, p = 0.047) but 5-10% higher rejection rates. Graft and patient survival were not negatively affected by the ESP allocation when compared to the standard allocation. The ESP age matching of elderly donors and recipients is an effective allocation system for organs from elderly donors.
authors.affiliation: Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Charité Campus-Virchow-Klinikum, Berlin, Germany. ulrich.frei@charite.de
authors.forename: U
authors.initials: U
authors.lastname: Frei
authors.forename: J
authors.initials: J
authors.lastname: Noeldeke
authors.forename: V
authors.initials: V
authors.lastname: Machold-Fabrizii
authors.forename: H
authors.initials: H
authors.lastname: Arbogast
authors.forename: R
authors.initials: R
authors.lastname: Margreiter
authors.forename: L
authors.initials: L
authors.lastname: Fricke
authors.forename: A
authors.initials: A
authors.lastname: Voiculescu
authors.forename: V
authors.initials: V
authors.lastname: Kliem
authors.forename: H
authors.initials: H
authors.lastname: Ebel
authors.forename: U
authors.initials: U
authors.lastname: Albert
authors.forename: K
authors.initials: K
authors.lastname: Lopau
authors.forename: P
authors.initials: P
authors.lastname: Schnuelle
authors.forename: B
authors.initials: B
authors.lastname: Nonnast-Daniel
authors.forename: F
authors.initials: F
authors.lastname: Pietruck
authors.forename: R
authors.initials: R
authors.lastname: Offermann
authors.forename: G
authors.initials: G
authors.lastname: Persijn
authors.forename: C
authors.initials: C
authors.lastname: Bernasconi
mesh_terms: D000367:Age Factors; D000368:Aged; D005060:Europe; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006650:Histocompatibility Testing / Q000706:statistics & numerical data; D006801:Humans; D016030:Kidney Transplantation / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D014019:Tissue Donors; D009927:Tissue and Organ Procurement / Q000706:statistics & numerical data; D014850:Waiting Lists